What changed after the 2022 guidelines for pulmonary hypertension?

Area of Science:

• Cardiology
• Respiratory Medicine
• Clinical Practice Guidelines

Background:

• Pulmonary hypertension (PH) affects approximately 1% of the global population, representing a significant health burden.
• Existing diagnostic and treatment protocols for PH are subject to periodic updates to reflect advancements in medical understanding and technology.

Purpose of the Study:

• To provide a comprehensive overview of the recent revisions in the European Society of Cardiology (ESC) /European Respiratory Society (ERS) guidelines for pulmonary hypertension (PH).
• To analyze the implications of these updated guidelines for the daily clinical management of patients with PH.

Main Methods:

• This study is a review article.
• It synthesizes information from the latest ESC/ERS guidelines on PH diagnosis and treatment.
• The review focuses on practical applications for clinicians.

Main Results:

• The revised ESC/ERS guidelines introduce novelties in the diagnostic algorithms for PH.
• Updated treatment strategies are presented, potentially altering patient management pathways.
• The guidelines emphasize a multidisciplinary approach to PH care.

Conclusions:

• The updated ESC/ERS guidelines offer significant advancements in the diagnosis and treatment of pulmonary hypertension.
• These revisions are expected to enhance clinical decision-making and improve patient outcomes in everyday practice.
• Adoption of these novelties is crucial for healthcare professionals managing PH patients.